ARTICLEhttps://harbor.dev.pubfactory.com/view/journals/jnccn/11/3/article-p232.xmlIn Chemotherapy for Lung Cancer, Sometimes Less is More2026-04-18https://harbor.dev.pubfactory.com/view/journals/jnccn/11/3/article-p232.pdf2026-04-18In Chemotherapy for Lung Cancer, Sometimes Less is Morehttps://harbor.dev.pubfactory.com/view/journals/jnccn/11/3/article-p229.xmlKeeping Cancer Patients Out of the Hospital at the End of Life2026-04-18https://harbor.dev.pubfactory.com/view/journals/jnccn/11/3/article-p229.pdf2026-04-18Keeping Cancer Patients Out of the Hospital at the End of Lifehttps://harbor.dev.pubfactory.com/view/journals/jnccn/11/3/article-pxxi.xmlOncology Research Program2026-04-18https://harbor.dev.pubfactory.com/view/journals/jnccn/11/3/article-pxxi.pdf2026-04-18Oncology Research Programhttps://harbor.dev.pubfactory.com/view/journals/jnccn/11/3/article-pxii.xmlNCCN News2026-04-18https://harbor.dev.pubfactory.com/view/journals/jnccn/11/3/article-pxii.pdf2026-04-18NCCN Newshttps://harbor.dev.pubfactory.com/view/journals/jnccn/11/3/article-pxxiii.xml JNCCN CE Offerings2026-04-18https://harbor.dev.pubfactory.com/view/journals/jnccn/11/3/article-pxxiii.pdf2026-04-18 JNCCN CE Offeringshttps://harbor.dev.pubfactory.com/view/journals/jnccn/11/3/article-p298.xmlOptimizing Neoadjuvant Therapy for Rectal Cancer With Oxaliplatin2026-04-18https://harbor.dev.pubfactory.com/view/journals/jnccn/11/3/article-p298.pdf2026-04-18Optimizing Neoadjuvant Therapy for Rectal Cancer With Oxaliplatinhttps://harbor.dev.pubfactory.com/view/journals/jnccn/11/3/article-p281.xmlPoint: Impact of Prostate-Specific Antigen Velocity on Management Decisions and Recommendations2026-04-18https://harbor.dev.pubfactory.com/view/journals/jnccn/11/3/article-p281.pdf2026-04-18Point: Impact of Prostate-Specific Antigen Velocity on Management Decisions and Recommendationshttps://harbor.dev.pubfactory.com/view/journals/jnccn/11/3/article-p286.xmlCounterpoint: Prostate-Specific Antigen Velocity Is Not of Value for Early Detection of Cancer2026-04-18https://harbor.dev.pubfactory.com/view/journals/jnccn/11/3/article-p286.pdf2026-04-18Counterpoint: Prostate-Specific Antigen Velocity Is Not of Value for Early Detection of Cancerhttps://harbor.dev.pubfactory.com/view/journals/jnccn/11/3/article-p275.xmlCutaneous T-Cell Lymphoma in Sub-Saharan Africa2026-04-18https://harbor.dev.pubfactory.com/view/journals/jnccn/11/3/article-p275.pdf2026-04-18Cutaneous T-Cell Lymphoma in Sub-Saharan Africahttps://harbor.dev.pubfactory.com/view/journals/jnccn/11/3/article-p257.xmlNon-Hodgkin’s Lymphomas, Version 1.20132026-04-18https://harbor.dev.pubfactory.com/view/journals/jnccn/11/3/article-p257.pdf2026-04-18Non-Hodgkin’s Lymphomas, Version 1.2013https://harbor.dev.pubfactory.com/view/journals/jnccn/11/3/article-p240.xmlPart 1: Abstracts From the NCCN 18th Annual Conference: Advancing the Standard of Cancer Care™2026-04-18https://harbor.dev.pubfactory.com/view/journals/jnccn/11/3/article-p240.pdf2026-04-18Part 1: Abstracts From the NCCN 18th Annual Conference: Advancing the Standard of Cancer Care™https://harbor.dev.pubfactory.com/view/journals/jnccn/11/3/article-p246.xmlAdjuvant Chemotherapy Decisions in Clinical Practice for Early-Stage Node-Negative, Estrogen Receptor-Positive, HER2-Negative Breast Cancer: Challenges and Considerations2026-04-18https://harbor.dev.pubfactory.com/view/journals/jnccn/11/3/article-p246.pdf2026-04-18Adjuvant Chemotherapy Decisions in Clinical Practice for Early-Stage Node-Negative, Estrogen Receptor-Positive, HER2-Negative Breast Cancer: Challenges and Considerationshttps://harbor.dev.pubfactory.com/view/journals/jnccn/11/3/article-p320.xmlCervical Cancer2026-04-18https://harbor.dev.pubfactory.com/view/journals/jnccn/11/3/article-p320.pdf2026-04-18Cervical Cancerhttps://harbor.dev.pubfactory.com/view/journals/jnccn/11/3/article-p348.xmlWhat Is the Appropriate Approach to Treating Women With Incurable Cervical Cancer?2026-04-18https://harbor.dev.pubfactory.com/view/journals/jnccn/11/3/article-p348.pdf2026-04-18What Is the Appropriate Approach to Treating Women With Incurable Cervical Cancer?https://harbor.dev.pubfactory.com/view/journals/jnccn/11/3/article-p357.xmlA Perspective on Dose Banding2026-04-18https://harbor.dev.pubfactory.com/view/journals/jnccn/11/3/article-p357.pdf2026-04-18A Perspective on Dose Bandinghttps://harbor.dev.pubfactory.com/view/journals/jnccn/11/3/article-p308.xmlMaintenance Therapy With Tyrosine Kinase Inhibitors After Transplant in Patients With Chronic Myeloid Leukemia2026-04-18https://harbor.dev.pubfactory.com/view/journals/jnccn/11/3/article-p308.pdf2026-04-18Maintenance Therapy With Tyrosine Kinase Inhibitors After Transplant in Patients With Chronic Myeloid Leukemiahttps://harbor.dev.pubfactory.com/view/journals/jnccn/11/suppl_1/article-pS-17.xmlProvision of Palliative Care and Pain Management Services for Oncology Patients2026-04-18https://harbor.dev.pubfactory.com/view/journals/jnccn/11/suppl_1/article-pS-17.pdf2026-04-18Provision of Palliative Care and Pain Management Services for Oncology Patientshttps://harbor.dev.pubfactory.com/view/journals/jnccn/11/suppl_1/article-pS-37.xmlEvidence-Based Treatment of Cancer-Related Breakthrough Pain With Opioids2026-04-18https://harbor.dev.pubfactory.com/view/journals/jnccn/11/suppl_1/article-pS-37.pdf2026-04-18Evidence-Based Treatment of Cancer-Related Breakthrough Pain With Opioidshttps://harbor.dev.pubfactory.com/view/journals/jnccn/11/suppl_1/article-pS-11.xmlBarriers and Approaches to the Successful Integration of Palliative Care and Oncology Practice2026-04-18https://harbor.dev.pubfactory.com/view/journals/jnccn/11/suppl_1/article-pS-11.pdf2026-04-18Barriers and Approaches to the Successful Integration of Palliative Care and Oncology Practicehttps://harbor.dev.pubfactory.com/view/journals/jnccn/11/suppl_1/article-pS-3.xmlEarly Implementation of Palliative Care Can Improve Patient Outcomes2026-04-18https://harbor.dev.pubfactory.com/view/journals/jnccn/11/suppl_1/article-pS-3.pdf2026-04-18Early Implementation of Palliative Care Can Improve Patient Outcomeshttps://harbor.dev.pubfactory.com/view/journals/jnccn/11/suppl_1/article-pS-1.xmlOptimal Cancer Care: Concurrent Oncology and Palliative Care2026-04-18https://harbor.dev.pubfactory.com/view/journals/jnccn/11/suppl_1/article-pS-1.pdf2026-04-18Optimal Cancer Care: Concurrent Oncology and Palliative Carehttps://harbor.dev.pubfactory.com/view/journals/jnccn/11/suppl_1/article-pS-29.xmlGuidelines for the Management of Breakthrough Pain in Patients With Cancer2026-04-18https://harbor.dev.pubfactory.com/view/journals/jnccn/11/suppl_1/article-pS-29.pdf2026-04-18Guidelines for the Management of Breakthrough Pain in Patients With Cancer